Rallybio Corporation Investor Relations Material
Latest events
Status Update
Rallybio Corporation
Q2 2025
7 Aug, 2025
Corporate Presentation
11 Jun, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Rallybio Corporation
Access all reports
Rallybio Corporation is a biotechnology company focused on developing therapies for rare and severe diseases. The company specializes in antibody and protein-based treatments targeting immune and hematological disorders. Its research and development efforts aim to address conditions with high unmet medical needs through clinical trials and collaborations with scientific partners. The company is headquartered in New Haven, Connecticut, and its shares are listed on the NASDAQ.
Key slides for Rallybio Corporation
Status Update
Rallybio Corporation
Corporate Presentation
Rallybio Corporation
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
RLYB
Country
🇺🇸 United States